Overactive bladder Posts on Medivizor
Navigation Menu

Overactive bladder Posts on Medivizor

Vibegron improves the treatment outcomes of patients with overactive bladder

Posted by on Apr 5, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the effectiveness of vibegron (RVT-901) in the treatment of overactive bladder (OAB). Researchers suggested that this is a good and safe therapy to treat these patients.  Some background Overactive bladder (OAB) is a condition that is present in 23.3% of Americans. It consists of an uncontrollable need to...

Read More

Is mirabegron a safe and effective treatment for overactive bladder symptoms?

Posted by on Mar 10, 2020 in Overactive bladder | 0 comments

In a nutshell This paper investigated the effectiveness and safety of mirabegron (Myrbetriq) for the treatment of symptoms of overactive bladder (OAB). Mirabegron appeared to be safe and effective for the treatment of OAB symptoms. Some background OAB is characterized by symptoms such as experiencing incontinence (urine leakage), having a strong urge...

Read More

Combining behavioral and drug therapies improves overactive bladder symptoms in men

Posted by on Feb 15, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the effects of combining behavioral and drug therapies in male patients with overactive bladder (OAB). Researchers suggested that this combined therapy improves OAB symptoms. Some background OAB is a common condition. It can include frequent and urgent urination, incontinence (urine leak) and/or waking up at night...

Read More

OnabotulinumtoxinA improves symptoms in patients with overactive bladder and urinary incontinence

Posted by on Feb 3, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the effectiveness and safety of onabotulinumtoxinA (OBTA; Botox) in patients with overactive bladder and urinary incontinence. Researchers suggested that OBTA was associated with an improvement in urinary symptoms in these patients. Some background Overactive bladder (OAB) is a chronic disabling condition. The...

Read More

Mirabegron improves the quality of life of older patients with overactive bladder

Posted by on Jan 10, 2020 in Overactive bladder | 0 comments

In a nutshell This study investigated the quality of life outcomes in patients with overactive bladder (OAB) of 65 years of age or more. Researchers suggested that patients with OAB who received mirabegron (Myrbetriq) had improved quality of life. Some background OAB consists of an uncontrolled need or urge to urinate. Some people will leak urine when...

Read More

The effectiveness of mirabegron for overactive bladder in patients aged 65 and older

Posted by on Dec 8, 2019 in Overactive bladder | 0 comments

In a nutshell This study aimed to investigate the effectiveness of mirabegron in patients aged 65 years or older with overactive bladder (OAB) and urinary incontinence (UI). This study found that mirabegron improved the symptoms in these patients. Some background Overactive bladder (OAB) occurs when the bladder muscle is too active. Instead of staying...

Read More

Can exercise intensity improve symptoms of overactive bladder in patients who are overweight?

Posted by on Nov 6, 2019 in Overactive bladder | 0 comments

In a nutshell This study compared the effects of high versus low-intensity exercise in overweight female patients with overactive bladder (OAB). The authors found that high-intensity exercise, but not low, decreased body fat and improved OAB symptoms for these patients. Some background OAB is a condition where a patient persistently...

Read More

Are two drugs more beneficial than one for treating patients with overactive bladder?

Posted by on Oct 5, 2019 in Overactive bladder | 0 comments

In a nutshell This article reviewed several studies that compared the effectiveness of two drugs compared to one drug for treating symptoms of overactive bladder (OAB). The authors concluded that the combination of mirabegron (Myrbetriq) and solifenacin (Vesicare) was more effective than each drug alone and had similar side effects in these...

Read More

Comparing antimuscarinic treatment duration for women with overactive bladder syndrome

Posted by on Aug 30, 2019 in Overactive bladder | 0 comments

In a nutshell This study investigated the risk of retreatment after 3 or 6 months of antimuscarinic therapy for overactive bladder (OAB). This study found that prolonged antimuscarinic treatment does not increase the risk of retreatment for OAB. Some background Overactive bladder (OAB) occurs when the bladder muscle is too active....

Read More

Looking for participants with benign prostatic hyperplasia and overactive bladder to test a new drug

Posted by on Aug 14, 2019 in Overactive bladder | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...

Read More